Navigation Links
Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007
Date:10/16/2007

- Presentations on long-term safety and cardiovascular safety of nebulized formoterol fumarate and safety/ efficacy of concomitant use with tiotropium

for treatment of COPD -

NAPA, Calif., Oct. 16 /PRNewswire/ -- Dey, L.P., a subsidiary of Mylan Inc. (NYSE: MYL), announces three clinical data presentations will be given at CHEST 2007, the annual scientific assembly of the American College of Chest Physicians (ACCP) on Wednesday, October 24, 2007 at the McCormick Place Convention Center in Chicago. Data will be presented from two safety studies that were included as part of the New Drug Application (NDA) filing to the U.S. Food and Drug Administration (FDA) for Perforomist(TM) Inhalation Solution. The third presents results from a Phase IIIb study of the concomitant use of Perforomist(TM) Inhalation Solution with tiotropium for the treatment of COPD.

Perforomist(TM) Inhalation Solution is the first and only FDA-approved nebulized form of formoterol fumarate and is indicated for long-term, twice- daily maintenance treatment of bronchoconstriction for emphysema and chronic bronchitis, also known as Chronic Obstructive Pulmonary Disease (COPD). Nebulizers convert liquid medication into a mist that patients inhale through a mouthpiece or face mask.

For those attending CHEST, the three presentations are available as follows:

-- "Long-Term Safety of Nebulized Formoterol in COPD: An Open-Label

Active-Control Extension Study" Poster # 239

-- "Cardiovascular Safety of Nebulized Formoterol in COPD Patients: A

Double-Blind, Placebo-Controlled Study" Poster # 238

-- "Safety and Efficacy of Concomitant Treatment with Nebulized Formoterol

and T
'/>"/>

SOURCE Dey, L.P.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
2. Byetta Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
3. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
4. Three New Drugs Mark New Era in Rheumatoid Arthritis Treatment
5. ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds for Solid Tumors Are to be Reported at ASCO
6. Separate Sets of Research Show Treatment Improved Quality of Life in as Early as Three Weeks; Patient Adherence to Medication is Multifactorial
7. Isotechnika Announces Interim Three Month Data from Phase 2b Kidney Transplant Trial
8. Spectrum Pharmaceuticals Announces Data From Three Oncology Programs Presented at the American Association of Cancer Research Annual Meeting
9. Data supporting three Antisoma programmes presented at AACR
10. EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds
11. Genetic Analysis Systems Enter the Clinical Mainstream
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... SHENZHEN, China , July 7, 2015 /PRNewswire/ -- ... ), a leading developer, manufacturer and marketer of ... to acquire the remaining stake in Wuhan Dragonbio ... million. Dragonbio is a domestic ... joint and other surgical products. Prior to today,s ...
(Date:7/7/2015)... 2015 EnteroMedics Inc. (NASDAQ: ETRM ), ... technology to treat obesity, metabolic diseases, and other gastrointestinal ... offering of 32,000,000 units. Each unit consists of one share ... purchase one share of common stock at a purchase ... units in the offering would result in them beneficially ...
(Date:7/7/2015)... July 7, 2015 Oasmia ... of drugs within human and veterinary oncology, today ... in the United States , ... leading companion animal therapeutic.      (Logo: ... ) , Paccal Vet-CA1 was ...
Breaking Medicine Technology:Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3Oasmia Pharmaceutical Launches US Brand and Sales Platform 2
... , , , ... service Contract Research Organization (CRO) founded in India, today announced the ... Application Suite (OLSAS) by going live with Oracle Siebel Clinical Trial ... , "We are excited to have the rollout of ...
... Aug. 5 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: ... a New Drug Submission (NDS) with the Therapeutic Products ... the antidepressant trazodone. , "We are pleased to file ... R. Howard-Tripp, President and Chief Executive Officer, Labopharm Inc. ...
Cached Medicine Technology:SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite 2Labopharm files New Drug Submission with Health Canada for novel antidepressant 2Labopharm files New Drug Submission with Health Canada for novel antidepressant 3
(Date:7/7/2015)... ... July 07, 2015 , ... On June 22nd-26th, 2015, ... of the National Baptist Convention 110th Annual Session of the National Baptist Congress ... collaboration of churches and their congregations, medical professionals and health-related organizations, this week ...
(Date:7/7/2015)... ... 2015 , ... Dr. Poneh Ghasri , cosmetic dentist in Los Angeles, ... is one of the fastest, easiest ways to brighten a smile. Stained teeth can ... and confidence. With the right teeth whitening treatment, patients can restore a more youthful ...
(Date:7/7/2015)... , ... July 07, 2015 , ... ... Ellen Purdy as the company’s new Chief Financial Officer, effective July 6th, 2015. ... experience in companies ranging from a multi-billion dollar, global chemical company to early ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... of unified communication management solutions, has announced the release of Service Pack ... service pack includes a number of enhancements to the already robust capabilities ...
(Date:7/7/2015)... ... 07, 2015 , ... Connexion Point is holding an onsite job fair to hire 400 people ... Place, Suite 100, this upcoming Wednesday, July 8, and Thursday, July 9, from 9:00 a.m. ... recruiting new applicants as well as holding onsite interviews. Interested parties are encouraged to ...
Breaking Medicine News(10 mins):Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 3Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 2Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 3Health News:Office Practicum Announces new CFO 2Health News:ISI Telemanagement Solutions, Inc. Releases Service Pack 5600 for Infortel® Select 2Health News:Connexion Point, a tech enabled healthcare services company, is holding on-site job fair July 8th and 9th to fill 400 positions at its new Memphis location 2
... new ways of controlling and treating breast cancer at ... (Monday 1 October 2007). , Dr Robert Clarke and ... have been investigating human breast cancers for the presence ... and can cause the cancer to recur - in ...
... 1 In honor of October, Breast Cancer,Awareness Month, ... the Cure,encourages San Diegans to participate in a number ... Komen for the Cure can help the,organization in its ... awareness in San Diego County. "We encourage all ...
... on Spotting Depression in Children, BETHLEHEM, Pa., Oct. ... by depression each year, but even as thousands of,sites ... and educate them,about the condition on National Depression Screening ... a largely overlooked part of our,population: children. In ...
... Jobs With ... Congressman Rodney Frelinghuysen, PARSIPPANY, N.J., Oct. 1 ... and rapidly increasing its,staffing since 2002 to support a growing ... Sankyo is,one of the few pharmaceutical companies experiencing steady and ...
... raise funds,through in-store ,pin-up, campaign, ALEXANDRIA, Va., Oct. ... Kmart has reinforced its,commitment to ADA and elevated its ... Partner (NSP). As a National Strategic,Partner, Kmart will raise ... and cure diabetes, and to improve the lives of ...
... bug busting approach to head lice is helping to reduce ... to a review in the October issue of Journal of ... Hygiene Concern led a review of studies carried out in ... The best results are obtained when parents are supplied with ...
Cached Medicine News:Health News:Manchester researchers announce new methods of beating breast cancer 2Health News:In Celebration of Breast Cancer Awareness Month, Susan G. Komen for the Cure San Diego Announces Opportunities for San Diegans to Get Involved in the Fight Against Breast Cancer 2Health News:In Celebration of Breast Cancer Awareness Month, Susan G. Komen for the Cure San Diego Announces Opportunities for San Diegans to Get Involved in the Fight Against Breast Cancer 3Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 2Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 3Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 4Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 5Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 2Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 3Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 4Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 5Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 6Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 7Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 8Health News:Kmart Steps Out to Fight Diabetes 2Health News:Kmart Steps Out to Fight Diabetes 3Health News:Multicountry review shows that Bug Buster Kits reduce head lice and social stigma 2Health News:Multicountry review shows that Bug Buster Kits reduce head lice and social stigma 3
For the quantitative in vitro determination of Lactate Dehydrogenase (LD) in serum and plasma....
Latex agglutination slide test for the qualitative and semi-quantitative determination of Anti-Streptolysin O (ASO) in human serum...
For the quantitative in vitro determination of IgE in Human Serum or Plasma....
For the quantitative in vitro determination of Carbon Dioxide in serum and plasma....
Medicine Products: